UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000003965 |
|---|---|
| Receipt number | R000004756 |
| Scientific Title | The role of TRIM family in rheumatic diseases and aquired immunodeficiency syndrome |
| Date of disclosure of the study information | 2010/08/01 |
| Last modified on | 2018/02/01 13:39:52 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The role of TRIM family in rheumatic diseases and aquired immunodeficiency syndrome
Acronym
The role of TRIM family in rheumatic diseases and aquired immunodeficiency syndrome
Scientific Title
The role of TRIM family in rheumatic diseases and aquired immunodeficiency syndrome
Scientific Title:Acronym
The role of TRIM family in rheumatic diseases and aquired immunodeficiency syndrome
Region
| Japan |
Condition
Condition
Behcet disease
Systemic lupus erythematosus
Sjogren's syndrome
HIV infection
Classification by specialty
| Clinical immunology | Infectious disease |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the difference in expression and functions of TRIM family proteins among the rheumatic diseases and their change by disease activity.
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
Expression levels of TRIM family genes
Expression levels of cytokine genes
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 16 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with Behcet disease, SLE, Sjogren's syndrome, HIV infection
Healthy control
Key exclusion criteria
none
Target sample size
300
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Ryusuke Yoshimi |
Organization
Yokohama City University Graduate School of Medicine
Division name
Department of Hematology and Clinical Immunology
Zip code
Address
3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, Japan
TEL
045-787-2630
yoshiryu@med.yokohama-cu.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Ryusuke Yoshimi |
Organization
Yokohama City University Graduate School of Medicine
Division name
Department of Hematology and Clinical Immunology
Zip code
Address
3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, Japan
TEL
045-787-2630
Homepage URL
yoshiryu@med.yokohama-cu.ac.jp
Sponsor or person
Institute
Department of Hematology and Clinical Immunology
Yokohama City University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Takeda Science Foundation
Mochida Memorial Foundation for Medical and Pharmaceutical Research
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
横浜市立大学附属病院(神奈川県)
血液・リウマチ・感染症内科
Department of Hematology and Clinical Immunology
Yokohama City University Graduate School of Medicine
Other administrative information
Date of disclosure of the study information
| 2010 | Year | 08 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2010 | Year | 07 | Month | 02 | Day |
Date of IRB
Anticipated trial start date
| 2010 | Year | 08 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We investigate expression levels of TRIM family and cytokine genes.
Management information
Registered date
| 2010 | Year | 07 | Month | 28 | Day |
Last modified on
| 2018 | Year | 02 | Month | 01 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004756
